Insider Trading activities at Tc Biopharm (holdings) Plc (TCBP)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tc Biopharm (holdings) Plc (TCBP) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tc Biopharm (holdings) Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1872812.

Total stock buying since 2022: $1,073,923.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.


3 insiders reported insider trading activities at Tc Biopharm (holdings) Plc (TCBP):
Insider trading activities of Randall Mark Edward
Insider trading activities of Renaissance Capital Partners Ltd
Insider trading activities of Randall Kenneth Edward

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Tc Biopharm (holdings) Plc (TCBP).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2022 230,803 $1,073,923 0 $0 0 $0

Table 2. Monthly summary of insider trading at Tc Biopharm (holdings) Plc (TCBP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2022-11 210,000 $1,050,000 0 $0 0 $0
2022-05 20,803 $23,923 0 $0 0 $0

Table 3. Detailed insider trading at Tc Biopharm (holdings) Plc (TCBP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2022-11-30 Randall Kenneth Edward (10% Owner) Buy 70,000 5.00 350,000
2022-11-30 Renaissance Capital Partners Ltd (10% Owner) Buy 70,000 5.00 350,000
2022-11-30 Randall Mark Edward (10% Owner) Buy 70,000 5.00 350,000
2022-05-24 Randall Kenneth Edward (10% Owner) Buy 20,803 1.15 23,923

Insider trading activities including stock purchases, stock sales, and option exercises of TCBP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tc Biopharm (holdings) Plc (symbol TCBP, CIK number 1872812) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.